INGRAM ROBERT ALEXANDER 4
4 · Black Diamond Therapeutics, Inc. · Filed Mar 18, 2022
Insider Transaction Report
Form 4
INGRAM ROBERT ALEXANDER
Director
Transactions
- Award
Common Stock
2022-03-18$3.02/sh+5,795$17,501→ 18,397 total
Footnotes (2)
- [F1]These shares were issued in accordance with the Issuer's Second Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer.
- [F2]The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on March 17, 2022.